Jefferies analyst Maury Raycroft reiterated a Hold rating and $7.00 price target on Kezar Life Sciences (NASDAQ: KZR)The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments